| Authors: |
Bowlus CL; Division of Gastroenterology and Hepatology, UC Davis Health, Sacramento, California, USA., Thorburn D; Sheila Sherlock Liver Centre, Royal Free Hospital, Institute for Liver and Digestive Health, University College of London, London, UK., Barclay ST; Walton Liver Clinic, Glasgow Royal Infirmary, Glasgow, UK., Joshi D; Institute of Liver Studies, King's College Hospital, NHS Foundation Trust, London, UK., Londoño MC; Liver Unit, Hospital Clínic Barcelona, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain., Mantry P; Methodist Dallas Medical Center, Dallas, Texas, USA., Safadi R; Liver Unit, Hadassah University Hospital, Jerusalem, Israel., Aricha R; Chemomab Therapeutics, Ltd., Tel Aviv, Israel ., Cirillo C; Chemomab Therapeutics, Ltd., Tel Aviv, Israel ., Frankel M; Chemomab Therapeutics, Ltd., Tel Aviv, Israel ., Lawler J; Chemomab Therapeutics, Ltd., Tel Aviv, Israel ., Vaknin I; Chemomab Therapeutics, Ltd., Tel Aviv, Israel ., Mor A; Chemomab Therapeutics, Ltd., Tel Aviv, Israel . |